Modeling the dynamics of hepatitis C virus with combined antiviral drug therapy: interferon and ribavirin
From MaRDI portal
Publication:2437016
Abstract: A mathematical modeling of Hepatitis C Virus (HCV) dynamics has been presented in this paper. The proposed model, which involves four coupled ordinary differential equations, describes the interaction of target cells (hepatocytes), infected cells, infectious virions and non-infectious virions. The model takes into consideration the addition of ribavirin to interferon therapy and explains the dynamics regarding biphasic and triphasic decline of viral load in the model. A critical drug efficiency parameter has been defined and it is shown that for efficiencies above this critical value, HCV is eradicated whereas for efficiencies lower this critical value, a new steady state for infectious virions is reached, which is lower than the previous steady state.
Recommendations
- Rich dynamics of hepatitis C viral infection with logistic proliferation
- Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy
- A Mathematical Model for the Dynamics of Hepatitis C
- Dynamic analysis of a mathematical model for HIV and Hepatitis C virus co-infection
- Optimally controlled treatment strategy using interferon and ribavirin for hepatitis C
Cites work
- A Geometric Approach to Global-Stability Problems
- Additive compound matrices and an inequality for eigenvalues of symmetric stochastic matrices
- Compound matrices and ordinary differential equations
- Evaluating treatment of hepatitis C for hemolytic anemia management
- HIV-1 infection and low steady state viral loads
- Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy
- Optimally controlled treatment strategy using interferon and ribavirin for hepatitis C
- Uniformly Persistent Systems
Cited in
(24)- Global analysis of a mathematical model for hepatitis C considering the host immune system
- Influence of intracellular delay on the dynamics of Hepatitis C virus
- Analysis of hepatitis C viral dynamics using Latin hypercube sampling
- Modelling hepatotoxicity and antiretroviral therapeutic effect in HIV/HBV coinfection
- The influence of vaccination on the control of JE with a standard incidence rate of mosquitoes, pigs and humans
- Machine learning for mathematical models of HCV kinetics during antiviral therapy
- Stochastic analysis of in-host HCV dynamics through budding and bursting process
- Threshold dynamics of HCV model with cell-to-cell transmission and a non-cytolytic cure in the presence of humoral immunity
- Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy
- Modeling the effect of non-cytolytic immune response on viral infection dynamics in the presence of humoral immunity
- Dynamical analysis of a class of hepatitis C virus infection models with application of optimal control
- Dynamics of an HBV Model with Drug Resistance Under Intermittent Antiviral Therapy
- Dynamics of hepatitis C virus infection: mathematical modeling and parameter estimation
- A theoretical model of chronic hepatitis B virus with suboptimal adherence and drug resistance
- Modeling of viral dynamics after liver transplantation in patients with chronic hepatitis B and D
- Towards prediction of HCV therapy efficiency
- Some sufficient conditions for global asymptotic stability of a hepatitis C virus mathematical model considering host immune system
- Observer‐based controller for treatment of hepatitis C infection using fractional order model
- Modeling hepatocyte apoptosis in chronic HCV infection with impulsive drug control
- vRNA structured population model for Hepatitis C virus dynamics
- Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis
- Hopf bifurcation and stability switches induced by humoral immune delay in hepatitis C
- Chronic hepatitis B infection and HBV DNA-containing capsids: modeling and analysis
- Evaluating treatment of hepatitis C for hemolytic anemia management
This page was built for publication: Modeling the dynamics of hepatitis C virus with combined antiviral drug therapy: interferon and ribavirin
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2437016)
